afamelanotide

This page covers all afamelanotide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Melanocyte-stimulating hormone receptor.

Targets

Melanocyte-stimulating hormone receptor

Marketed (1)

• Scenesse · Clivunel Inc · Rare Disease

Patent intelligence

• afamelanotide patent landscape — aggregated cliff calendar, attackable patents, originator estates